rs547488738

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_001164278.2(SLC37A4):ā€‹c.1133G>Cā€‹(p.Ser378Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000487 in 1,613,380 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00026 ( 0 hom., cov: 33)
Exomes š‘“: 0.00051 ( 9 hom. )

Consequence

SLC37A4
NM_001164278.2 missense

Scores

1
4
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 5.62
Variant links:
Genes affected
SLC37A4 (HGNC:4061): (solute carrier family 37 member 4) This gene regulates glucose-6-phosphate transport from the cytoplasm to the lumen of the endoplasmic reticulum, in order to maintain glucose homeostasis. It also plays a role in ATP-mediated calcium sequestration in the lumen of the endoplasmic reticulum. Mutations in this gene have been associated with various forms of glycogen storage disease. Alternative splicing in this gene results in multiple transcript variants.[provided by RefSeq, Aug 2009]
TRAPPC4 (HGNC:19943): (trafficking protein particle complex subunit 4) Involved in autophagy and endoplasmic reticulum to Golgi vesicle-mediated transport. Part of TRAPP complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a transmembrane_region Helical (size 20) in uniprot entity G6PT1_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_001164278.2
BP4
Computational evidence support a benign effect (MetaRNN=0.009851992).
BP6
Variant 11-119025247-C-G is Benign according to our data. Variant chr11-119025247-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 199062.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000256 (39/152358) while in subpopulation SAS AF= 0.00807 (39/4832). AF 95% confidence interval is 0.00607. There are 0 homozygotes in gnomad4. There are 28 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC37A4NM_001164278.2 linkuse as main transcriptc.1133G>C p.Ser378Thr missense_variant 11/12 NP_001157750.1 O43826-2A0A024R3L1
SLC37A4NM_001164277.2 linkuse as main transcriptc.1067G>C p.Ser356Thr missense_variant 10/11 NP_001157749.1 O43826-1A0A024R3H9A8K0S7
SLC37A4NM_001164280.2 linkuse as main transcriptc.1067G>C p.Ser356Thr missense_variant 8/9 NP_001157752.1 O43826-1A0A024R3H9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC37A4ENST00000330775.9 linkuse as main transcriptc.1067G>C p.Ser356Thr missense_variant 9/105 ENSP00000476242.2 U3KPU7

Frequencies

GnomAD3 genomes
AF:
0.000256
AC:
39
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00806
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00109
AC:
270
AN:
247428
Hom.:
3
AF XY:
0.00135
AC XY:
181
AN XY:
134256
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000112
Gnomad SAS exome
AF:
0.00877
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000511
AC:
747
AN:
1461022
Hom.:
9
Cov.:
34
AF XY:
0.000724
AC XY:
526
AN XY:
726740
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00820
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000547
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.000376
AC XY:
28
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00807
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000128
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.00119
AC:
144
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 16, 2015- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Glucose-6-phosphate transport defect Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 12, 2019- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 09, 2022The p.S356T variant (also known as c.1067G>C), located in coding exon 7 of the SLC37A4 gene, results from a G to C substitution at nucleotide position 1067. The serine at codon 356 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
SLC37A4-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 16, 2022This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
22
DANN
Benign
0.93
DEOGEN2
Benign
0.12
T;T;T;T
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.88
.;D;D;D
MetaRNN
Benign
0.0099
T;T;T;T
PrimateAI
Uncertain
0.63
T
Sift4G
Uncertain
0.010
D;D;D;D
Vest4
0.31
MVP
0.39
MPC
0.026
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs547488738; hg19: chr11-118895957; COSMIC: COSV58155939; COSMIC: COSV58155939; API